Stock Analysts

Agios (AGIO) Files NDA for Leukemia Candidate in the U.S.

Agios Pharmaceuticals, Inc. AGIO announced that it has submitted a new drug application (“NDA”) to the FDA for its investigational candidate ivosidenib (AG-120) for treatment of patients with relapsed or refractory acute myeloid leukemia (R/R AML) and an isocitrate dehydrogenase-1 (IDH1) mutation. Notably, the company has requested the regulatory agency for a priority review keeping in mind that the latter would have to complete the process within a span of six months if it accepts the application […]

Stock Analysts

Why Halliburton Is a Better Stock than Schlumberger for 2018

Among the major oilfield services firms, Schlumberger Limited ( SLB ) and Halliburton Company ( HAL ) deserve a special mention, given their massive market caps of $86.4 billion and $38.8 billion, respectively. These companies dominate and define the industry to which they belong to. Both of these firms have interesting earnings surprise histories. […]

Stock Analysts

McDermott Gets EPCC Contract From Maersk Oil in North Sea

Energy-focused engineering and construction company McDermott International, Inc. MDR recently announced that it has landed an engineering, procurement, construction and commissioning (EPCC) services contract from Maersk Oil for the latter's Tyra Redevelopment project. It is located in the Danish sector of North Sea. […]

Stock Analysts

Should Value Investors Consider Kingstone (KINS) Stock?

Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing discounts when compared to fair value? One way to find these companies is by looking at several key metrics and financial ratios, many of which are crucial in the value stock selection process […]